Assignee
FRESENIUS KABI IPSUM S R L
IT·9 granted patents·4 pending applications·7 citations·filing 2016–2022
Top patents by PatentIndex Score
13 records- 0184US10414830B2Crystalline forms of per-chloro-γ-cyclodextrinesFRESENIUS KABI IPSUM S R L·Filed 2016·Granted Sep 17, 2019·2 cites·11 claims
- 0282US10414829B2Process for the preparation of sugammadex and its intermediatesFRESENIUS KABI IPSUM S R L·Filed 2016·Granted Sep 17, 2019·2 cites·12 claims
- 0377US11014919B2Process for the preparation of alectinibFRESENIUS KABI IPSUM S R L·Filed 2019·Granted May 25, 2021·2 cites·16 claims
- 0477US10577433B2Process for the preparation of sugammadexFRESENIUS KABI IPSUM S R L·Filed 2017·Granted Mar 3, 2020·1 cites·17 claims
- 0563US12098218B2Process for the manufacture of degarelix and its intermediatesFRESENIUS KABI IPSUM S R L·Filed 2021·Granted Sep 24, 2024·0 cites·13 claims
- 0655US2022009917A1Process for the preparation of alectinibFRESENIUS KABI IPSUM S R L·Filed 2021·Application pending·0 cites
- 0751US12497644B2Subtilisin variants and their useFRESENIUS KABI IPSUM S R L·Filed 2022·Granted Dec 16, 2025·0 cites·22 claims
- 0851US11168114B2Process for the manufacture of degarelix and its intermediatesFRESENIUS KABI IPSUM S R L·Filed 2016·Granted Nov 9, 2021·0 cites·14 claims
- 0949US2022324936A1Process for the manufacture of glucagonFRESENIUS KABI IPSUM S R L·Filed 2020·Application pending·0 cites
- 1048US11566058B2Process for the preparation of high purity glucagonFRESENIUS KABI IPSUM S R L·Filed 2020·Granted Jan 31, 2023·0 cites·10 claims
- 1143US11396533B2Process for the manufacture of GLP-1 analoguesFRESENIUS KABI IPSUM S R L·Filed 2019·Granted Jul 26, 2022·0 cites·15 claims
- 1243US2022177521A1Process for the preparation of degarelixFRESENIUS KABI IPSUM S R L·Filed 2020·Application pending·0 cites
- 1340US2021238230A1A method for production of high purity icatibantFRESENIUS KABI IPSUM S R L·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when FRESENIUS KABI IPSUM S R L files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →